Login to Your Account



Pharma: Other News To Note


Thursday, September 26, 2013
• Mylan Inc., of Pittsburgh, said it has been sued by New York-based Forest Laboratories Inc., Forest Laboratories Holdings Ltd. and Royalty Pharma Collection Trust in connection with the filing of an abbreviated new drug application with FDA for Milnacipran HCl Tablets 12.5 mg, 25 mg, 50 mg and 100 mg.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription